Winter storm warnings in northern Minnesota

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Insulin is a matter of life and death for people with type 1 diabetes. But the cost of staying alive is increasingly steep.

 The price of a vial of insulin doubled between 2012 and 2016

 – a jump no one can adequately explain. In response, diabetics

 – and many are dying because of it. Some are even

, where the cost of insulin is often one-tenth of what it is in the U.S.

. After it failed in the spring, there’s movement on a plan to get emergency insulin to those who need it. But right now, no one is sure how to pay for it, and it faces other hurdles for passage.

So what’s next? Tuesday, Kerri Miller spoke with two of the world’s leading diabetes researchers about the problem of insulin’s skyrocketing price and alternatives diabetics might have in the future for managing the disease.

Shows

Big Books & Bold Ideas with Kerri Miller

Host

Author

People with type 1 diabetes need insulin to live. But the price of insulin has nearly tripled in a decade. What does this mean – and what is research finding about alternatives?

People with type 1 diabetes need insulin to live. But the price of insulin has nearly tripled in a decade. What does this mean - and what is research finding about alternatives?

The true cost of the high price of insulin

Go Deeper.

Like this?

News you can use in your inbox